Nanotechnology holds the promise of revolutionizing the way medicine wages war against cancer, from providing new ways to combine drugs to delivering gene-silencing therapeutics for cancer cells. To more fully understand the impact, The Kavli Foundation held a roundtable teleconference with four pioneers in the field, including KNI Board member Jim Heath, and Caltech colleague, Mark E. Davis.
